Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 38 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

15 recruiting

Enrollment Performance

Analytics

N/A
33(86.8%)
Phase 1
4(10.5%)
Early Phase 1
1(2.6%)
38Total
N/A(33)
Phase 1(4)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (38)

Showing 20 of 38 trials
NCT06112652Not ApplicableSuspended

Neuromodulation of Different Doses to Treat TRD Guided by pBFS Technique

Role: lead

NCT07570212Not ApplicableRecruiting

Individualized Transcranial Magnetic Stimulation in Parkinsonian Disorders

Role: collaborator

NCT05842291Not ApplicableSuspended

pBFS Guided High-dose rTMS Therapy for Treatment-Resistant Depression

Role: lead

NCT06919822Not ApplicableRecruiting

SCAN Targeted Epidural Modulation for Parkinson's Disease

Role: lead

NCT07411781Phase 1Not Yet Recruiting

PIN in Combination With Sintilimab in Previously Treated pMMR/MSS CRC With Hepatic Metastases

Role: collaborator

NCT07144735Not ApplicableRecruiting

Allogeneic γδT Cells in Glioblastoma

Role: collaborator

NCT07018518Phase 1Recruiting

PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma

Role: collaborator

NCT06883149Phase 1Recruiting

PIN in Combination With Anti-PD1 in Previously Treated Solid Tumor

Role: collaborator

NCT05953415Not ApplicableRecruiting

pBFS-guided iTBS Over the Left DLPFC for Chronic PSCI

Role: lead

NCT05969548Not ApplicableRecruiting

pBFS-guided cTBS at Different Doses for Aphasia After Stroke

Role: lead

NCT05957354Not ApplicableRecruiting

pBFS-guided Dual-target cTBS for Aphasia After Stroke

Role: lead

NCT05907031Not ApplicableRecruiting

pBFS-guided cTBS Over the Inferior Frontal Gyrus for Aphasia After Ischemic Stroke

Role: lead

NCT05957445Not ApplicableRecruiting

pBFS-guided Multi-target cTBS for Aphasia After Stroke

Role: lead

NCT05999318Not ApplicableRecruiting

pBFS-guided cTBS Over the Superior Temporal Gyrus for Aphasia After Ischemic Stroke

Role: lead

NCT06255535Not ApplicableRecruiting

pBFS Guided rTMS Over Cognitive Control Network for ASD

Role: lead

NCT06819358Early Phase 1Not Yet Recruiting

Individualized Functional Imaging-Guided Repetitive Transcranial Magnetic Stimulation (rTMS) for Treating Postural Gait Disorders in Patients with Amyotrophic Lateral Sclerosis (ALS): a Randomized, Crossover, Controlled, Double-Blind Clinical Study

Role: collaborator

NCT06734676Not ApplicableCompleted

fMRI-guided Transcranial Magnetic Stimulation Treatment for Parkinson's Disease

Role: lead

NCT05842304Not ApplicableRecruiting

Individualized Precision rTMS for Language Recovery in Patients After Ischemic Stroke: a Multi-center RCT

Role: lead

NCT06373991Phase 1Not Yet Recruiting

A Study to Evaluate the Safety and Efficacy of ATHENA CAR-T in Subjects With Systemic Lupus Erythematosus

Role: collaborator

NCT06350396Not ApplicableRecruiting

pBFS-guided rTMS Over DMPFC for Treatment-Resistant Depression

Role: lead